Plasmodium malariae infection in spite of previous anti-malarial medication

Parasitology Research

Volumn 102, Issue 3, 2008, Pages 547-550

  Müller Stöver, Irmela ^a   Verweij, Jaco J ^b   Hoppenheit, Barbara ^a   Göbels, Klaus ^a   Häussinger, Dieter ^a   Richter, Joachim ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; MEFLOQUINE;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; CASE REPORT; CELL MATURATION; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DRUG EFFECT; ECHOGRAPHY; ERYTHROCYTE; HUMAN; LABORATORY TEST; MALARIA; MALE; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; PLASMODIUM MALARIAE; PRIORITY JOURNAL; TREATMENT FAILURE;

ADULT; ANIMALS; ANTIMALARIALS; DNA, PROTOZOAN; GERMANY; GHANA; HUMANS; KENYA; MALARIA; MALE; MIDDLE AGED; PLASMODIUM MALARIAE; POLYMERASE CHAIN REACTION; TRAVEL;

PLASMODIUM MALARIAE;

EID: 38549125533     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-007-0804-4     Document Type: Article

References (12)

1. Adegnika AA, Verweij JJ, Agnandji ST, Chai SK, Breitling LP, Ramharter M, Frolich M, Issifou S, Kremsner PM, Yazdanbakhsh M (2006) Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. Am J Trop Med Hyg 75:798-803
2. Baas MC, Wetsteyn JCFM, van Gool T (2006) Patterns of imported malaria at the Academic Medical Center, Amsterdam, the Netherlands. J Travel Med 13:2-7
3. Gilles HM, Warrel DA (1993) Bruce-Chwatts essential malariology, 3rd edn. Arnold, London, p 340
4. Grobusch MP, Göbels K, Teichmann D (2004) Is quartan malaria safely prevented by mefloquine prophylaxis? J Travel Med 11:125-126
5. Hess FJ, Kilian AD, Nothdurft HD, Löscher T (1993) Problems in the therapy of mixed malarial infection: a case of infection with Plasmodium falciparum and P. malariae treated with mefloquine and halofantrine. Trans R Soc Trop Med Hyg 87:688
6. Hogh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Gunther M, Joubert I, Kain KC, Shaw D, Roskell NS, Chulay JD (2000) Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet 356:1888-1894
7. Maguire JD, Sumawinata IW, Masbar S, Laksana B, Prodjodipuro P, Susanti I, Sismadi P, Mahmud N, Bangs MJ, Baird JK (2002) Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 360:58-60
8. Mehlhorn H, Eichenlaub D, Löscher T, Peters W (1995) Diagnostik und Therapie der Parasitosen des Menschen. Gustav Fischer, Stuttgart, p 134
9. Niesters HG (2002) Clinical virology in real time. J Clin Virol 25(Suppl 3):S3-S12
10. Radloff PD, Philipps J, Hutchinson D, Kremsner PG (1996) Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria. Trans R Soc Trop Med Hyg 90:682
11. Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB (1999) Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33:704-711
12. White NJ (2002) Malaria. In: Cook GC, Zumla A (eds) Manson's tropical diseases, 21st edn. Saunders, Philadelphia, pp 1205-1295